Bookmark

Add to MyYahoo RSS

Cholesterol News

News on Cholesterol continually updated from thousands of sources around the net.

20 hrs ago | Medical News Today

Sanofi and Regeneron report positive top-line results from nine phase ...

Sanofi and Regeneron Pharmaceuticals, Inc. have announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks compared to placebo or active comparator.

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Health, Zetia, Ezetimibe (generic), Lipitor, Atorvastatin (generic)

Yesterday | CiteULike

Antioxidant Supplements Block the Response of HDL to...

Arteriosclerosis, Thrombosis, and Vascular Biology , Vol. 21, No. 8. , pp. 1320-1326, doi:10.1161/hq0801.095151 One strategy for treating coronary artery disease patients with low HDL cholesterol is to maximally increase the HDL-C to LDL-C ratio by combining lifestyle changes with niacin plus a statin.

Comment?

Related Topix: Medicine, Health, Niacin (generic), Niaspan, Niacor, Zocor, Simvastatin (generic)

Thu Jul 31, 2014

Medical News Today

What are the health benefits of edamame?

Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.

Comment?

Related Topix: Medicine, Health, Life, Food, Dieting, Vitamin C, Supplement, Thiamin, Vitamin E, Vegetables

Wed Jul 30, 2014

Reuters

UPDATE 1-Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints

A new drug being developed by Sanofi SA and Regeneron Pharmaceuticals Inc cut cholesterol in nine late-stage clinical trials, the companies said on Wednesday, and provided the first glimpse of its potential to prevent heart attacks and strokes.

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Health, Amgen

P&T Community

Positive Results Reported From Nine Phase III Trials of Alirocumab in Hypercholesterolemia

Nine new phase III studies of alirocumab in patients with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks compared with placebo or an active comparator.

Comment?

Related Topix: Medicine, Health, Angina, Zetia, Ezetimibe (generic), Lipitor, Atorvastatin (generic)

TheStreet.com

Jim Cramer's Mad Dash: Good News for Regeneron

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Mozilla, Medicine, Health

Reuters

Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials

A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.

Comment?

Related Topix: Medicine, Health, Biotech, Amgen, Healthcare Industry

Tue Jul 29, 2014

Bradenton.com

Pfizer's 2Q profit sinks 79 pct but tops forecasts

The latest results still edged analyst expectations. The New York company said Tuesday it earned $2.91 billion, or 45 cents per share, in the quarter.

Comment?

Related Topix: Pfizer, Biotech, Healthcare Industry, Erectile Dysfunction, Health, Lipitor, Atorvastatin (generic)

Mon Jul 28, 2014

Fox News

Drugs to increase 'good' cholesterol may not cut deaths

Drugs that have been investigated to increase so-called "good" cholesterol may not prevent deaths, heart attacks or strokes as many hoped, according to a new analysis.

Comment?

Related Topix: Medicine, Health

Reuters

Drugs to increase 'good' cholesterol may not cut deaths

Drugs that have been investigated to increase so-called "good" cholesterol may not prevent deaths, heart attacks or strokes as many hoped, according to a new analysis.

Comment?

Related Topix: Medicine, Health, Heart Disease

Sun Jul 27, 2014

The Times Bulletin

Men who take statins may exercise less

Older men taking the cholesterol-lowering drugs known as statins appear to be slightly less active than those who don't take them, a new study suggests.

Comment?

Related Topix: Medicine, Health, Zocor, Simvastatin (generic), Fluvastatin (generic), Lescol, Lescol XL, Pravachol, Pravastatin (generic), Lipitor, Atorvastatin (generic), Oregon Health & Science University

Sat Jul 26, 2014

Medical News Today

Barrett's esophagus less of a risk for those on statins

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology1, the official journal of the American Gastroenterological Association.

Comment?

Related Topix: Medicine, Health, Baylor College of Medicine

Fri Jul 25, 2014

Medical News Today

Earlier, more aggressive cholesterol-lowering treatment suggested for ...

New guidelines on cholesterol treatment and cardiovascular risk assessment state that men have at least double the risk of dying from atherosclerotic cardiovascular disease or of having a heart attack or stroke as do women with a similar risk profile .

Comment?

Related Topix: Medicine, Health, Mayo Clinic Rochester, Hospital Administration, Healthcare Industry

PeoriaTimes-Observer

Health Watch: Go the extra mile

If you take the bus to work, there's a simple way to sneak in a little extra exercise: Instead of jumping on at your usual stop, walk a mile to the next one down the line.

Comment?

Related Topix: Medicine, Health, Family, Teenagers, Drugs, Marijuana

Thu Jul 24, 2014

The Motley Fool

Pfizer's Incoming Patent Cliff

The big pharma giant's loss of patent exclusivity on the world's former top-selling drug, cholesterol fighter Lipitor, has cost its drug revenues dearly.

Comment?

Related Topix: Medicine, Health, Lipitor, Atorvastatin (generic), Celebrex, Celecoxib (generic), Pain

Wed Jul 23, 2014

NBC Los Angeles

National Blood Shortage Looming: Red Cross

A new study links the cholesterol-lowering prescription drug Niacin to diabetes, gastric bleeding and an increased risk of death for some people.

Comment?

Related Topix: Medicine, Niacin (generic), Niaspan, Niacor, Health, Duarte, CA

Hispanic Business

New Findings from Department of Nephrology Update Understanding of...

Pharmacotherapy with mTOR inhibitors aggravates dyslipidemia, thus necessitating lipid-lowering therapy with fluvastatin, pravastatin, or atorvastatin."

Comment?

Related Topix: Nephrology, Medicine, Fluvastatin (generic), Lescol, Lescol XL, Pravachol, Pravastatin (generic), Lipitor, Atorvastatin (generic), Health

PhysOrg Weblog

Statin use decreases the risk of Barrett's esophagus

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology , the official journal of the American Gastroenterological Association.

Comment?

Related Topix: Medicine, Health, Gastroenterology, Baylor College of Medicine

Forbes.com

Niacin, Heart Disease And The Fallacy That All Older Drugs Are Safe And Effective

Back in the late 1990s, I became concerned that my LDL cholesterol levels were getting too high.

Comment?

Related Topix: Medicine, Niacin (generic), Niaspan, Niacor, Heart Disease, Health, Life, Food, Dieting, Lipitor, Atorvastatin (generic)

Tue Jul 22, 2014

CiteULike

Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

Comment?

Related Topix: Niacin (generic), Niaspan, Niacor, Medicine, Health, Heart Disease

•••
•••
•••
•••
•••
•••
•••
•••